It is not in the financial interests of the pharmaceutical industry to
prevent or cure common diseases but rather manage them in the most profitable
way.
The maintenance and expansion of diseases is a precondition for the financial
growth of the pharmaceutical "disease business".
1 The
pharmaceutical industry is an investment industry driven by the profits of its
shareholders. Improving human health is not the driving force of this industry.
2 The
pharmaceutical investment industry was artificially created and strategically
developed over an entire century by the same investment groups that control the
global petrochemical and chemical industries.
3 The
huge profits of the pharmaceutical industry are based on the patenting of new
drugs. These patents essentially allow drug manufacturers to arbitrarily define
the profits for their products.
4 The
marketplace for the pharmaceutical industry is the human body – but only for
as long as the body hosts diseases. Thus, maintaining and expanding diseases is
a precondition for the growth of the pharmaceutical industry.
5 A key
strategy to accomplish this goal is the development of drugs that merely mask
symptoms while avoiding the curing or elimination of diseases. This explains why
most prescription drugs marketed today have no proven efficacy and merely target
symptoms.
6 To
further expand their pharmaceutical market, the drug companies are continuously
looking for new applications (indications) for the use of drugs they already
market. For example, Bayer’s pain pill Aspirin is now taken by 50 million
healthy US citizens under the illusion it will prevent heart attacks.
7 Another
key strategy to expand pharmaceutical markets is to cause new diseases with
drugs. While merely masking symptoms short term, most of the prescription drugs
taken by millions of patients today cause a multitude of new diseases as a
result of their known long-term side effects. For example, all
cholesterol-lowering drugs currently on the market are known to increase the
risk of developing cancer – but only after the patient has been taking the
drug for several years.
8 The
known deadly side effects of prescription drugs are the fourth leading cause of
death in the industrialized world, surpassed only by the number of deaths from
heart attacks, cancer and strokes (Journal of the American Medical Association,
April 15, 1998). This fact is no surprise either, because drug patents are
primarily issued for new synthetic molecules. All synthetic molecules need to be
detoxified and eliminated from the body, a system that frequently fails and
results in an epidemic of severe and deadly side effects.
9 While
the promotion and expansion of diseases increase the market of the
pharmaceutical investment industry - prevention and root cause treatment of
diseases decrease long-term profitability; therefore, they are avoided or even
obstructed by this industry.
10 Worst
of all, the eradication of diseases is by its very nature incompatible with and
diametrically opposed to the interests of the pharmaceutical investment
industry. The eradication of diseases now considered as potential drug markets
will destroy billions of investment dollars and eventually will eliminate this
entire industry.
11 Vitamins
and other effective natural health therapies that optimize cellular metabolism
threaten the pharmaceutical "business with disease" because they
target the cellular cause of today’s most common diseases - and these natural
substances cannot be patented.12
Throughout the more than one hundred year existence of the pharmaceutical
industry, vitamins and other essential nutrients, with defined functions as
cofactors in cellular metabolism, have been the fiercest competition and the
greatest threat to the long-term success of the pharmaceutical investment
business.
13 Vitamins
and other effective natural health therapies that effectively prevent diseases
are incompatible with the very nature of the pharmaceutical "business with
disease."14 To protect the strategic development of its investment business
against the threat from effective, natural and non-patentable therapies, the
pharmaceutical industry has – over an entire century - used the most
unscrupulous methods, such as:
|
(1)
|
Withholding life-saving health information from millions
of people. It is simply unacceptable that today so few know that the
human body cannot produce vitamin C and lysine, two key molecules for
connective tissue stability and disease prevention.
|
|
(2)
|
Discrediting natural health therapies. The most common
way is through global PR campaigns organized by the Pharma-Cartel that
spread lies about the alleged side effects of natural substances –
molecules that have been used by Nature for millennia.
|
|
(3)
|
Banning by law the dissemination of information about
natural health therapies. To that end, the pharmaceutical industry has
placed its lobbyists in key political positions in key markets and
leading drug export nations.
|
15 The
pharmaceutical "business with disease"
is the largest deception and fraud business in human history. The product
"health" promised by drug companies is not delivered to millions of
patients. Instead, the "products" most often delivered are the
opposite: new diseases and frequently, death. [I think the petroleum
industry would have to appear somewhere on the list - i.e., for suppression of
free energy.]
16 The
survival of the pharmaceutical industry is dependent on the elimination by any
means of effective natural health therapies. These natural and non-patentable
therapies have become the treatment of choice for millions of people despite the
combined economic, political and media opposition of the world’s largest
investment industry.
"The combined profits for the 10 drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion) in 2002. Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself." (ABC Lateline)
Check out her book if you like:
The Truth About the Drug Companies:
How They Deceive Us and What to Do About It
Marcia Angell
Marcia Angell, M.D. (born April 20, 1939 in Knoxville, TN) is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine (NEJM). She currently is a Senior Lecturer in the Department of Social Medicine at Harvard Medical School in Boston, Massachusetts.
Marcia Angell Speaks on Drug Companies Epic Profits
- Dr. Marcia Angell, former editor in chief of the New England Journal of Medicine
"The combined profits for the 10 drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion) in 2002. Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself." (ABC Lateline)
Check out her book if you like:
The Truth About the Drug Companies:
How They Deceive Us and What to Do About It
Marcia Angell
Marcia Angell, M.D. (born April 20, 1939 in Knoxville, TN) is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine (NEJM). She currently is a Senior Lecturer in the Department of Social Medicine at Harvard Medical School in Boston, Massachusetts.
